Navigation Links
Breast cancer drug shows promise for treating, preventing progestin-dependent tumors
Date:1/28/2009

COLUMBIA, Mo. Recent studies suggest that human breast cancer risk is increased by outside exposure to the hormone progestin, such as during hormone replacement therapy. Now, a University of Missouri study suggests that PRIMA-1, a small molecule drug that targets the most common mutated gene, p53, in human cancer cells, has potential as a novel chemotherapeutic treatment for progestin-accelerated human breast cancer.

"We demonstrated that PRIMA-1 was an effective drug to treat and prevent emergence of progestin-accelerated mammary tumors in rats," said Salman Hyder, professor of biomedical sciences in the College of Veterinary Medicine and the Dalton Cardiovascular Research Center. "The results of this study may have significant implications for the treatment and prevention of human breast cancer because such a large fraction of human breast cancers are dependent on estrogens and progestins for growth."

Mutated p53 plays a key role in promoting tumor cell survival and tumor cell resistance to chemotherapeutic drugs. In more than 50 percent of breast cancer cases, mutated p53 is present. Previous research has indicated that when p53 is functionally abnormal, tumor cells are prolific and develop quickly. PRIMA-1 targets and returns normal function to the mutated p53.

In the study, researchers examined the ability of PRIMA-1 to suppress growth of progestin-accelerated, mammary tumors in an animal model. When tumors reached a certain size, researchers administrated PRIMA-1 twice a day for three days. The researchers found that PRIMA-1 caused regression of approximately 40 percent of progestin-accelerated mammary tumors. However, the drug did not induce regression of native, non-progestin accelerated tumors. PRIMA-1 also suppressed the emergence of any new progestin-accelerated tumors in the animal model.

"Postmenopausal women worldwide are exposed to exogenous progestin in the form of hormone replacement therapy, and clini
'/>"/>

Contact: Kelsey Jackson
JacksonKN@missouri.edu
573-882-8353
University of Missouri-Columbia
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Survival differences by race most apparent in advanced stages of breast cancer
2. MRI finds breast cancer before it becomes dangerous
3. Pathway links inflammation, angiogenesis and breast cancer
4. Drop in breast cancer incidence linked to hormone use, not mammograms
5. Breast cancer prevention practices vary across Canada
6. Eating junk food whilst pregnant and breastfeeding may lead to obese offspring
7. Acrylamide Wont Raise Breast Cancer Risk
8. New link between estrogen and breast cancer
9. Hypnosis Eases Pain of Breast Cancer Surgery
10. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
11. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... August 28, 2015 , ... With the goal of ... for the second year to the Adams County Fairgrounds in Mendon, IL on May ... raise money to support music education in the underfunded school districts of Mendon and ...
(Date:8/28/2015)... ... August 28, 2015 , ... The 6th Annual Survivor ... Aneurysm Foundation has added yet another accolade to its cadre of widespread support—an official ... , “With the help of the medical community and the University of Illinois at ...
(Date:8/28/2015)... ... ... “ Frequentz ” was featured on NewsWatch as part of its monthly ... for iOS, Android, and Windows. Joe Toohey, the host of AppWatch and technology expert, ... track product movement from beginning to end. , Businesses benefit greatly from having the ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Nashville Business Journal recently ... in business. Mr. Troy Mizell, Chairman of the Board at MyGenetx, is ... 2015 Veterans Awards will recognize Nashville military veterans who, through their professional and ...
(Date:8/28/2015)... Rochester, NY (PRWEB) , ... August 28, 2015 , ... ... injectable, Kybella™. It is the first and only nonsurgical product approved by the ... Dr. Vito Quatela and Dr. William Koenig are among ...
Breaking Medicine News(10 mins):Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 3Health News:Track Product Movement from Beginning to End with Frequentz 2Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3
... CEPH ) announced today that the underwriters ... aggregate principal amount of 2.50% convertible senior subordinated notes ... to purchase $65 million of additional notes, bringing the ... $500 million. Completion of the notes offering, including the ...
... Ontario Systems, a leading provider of revenue cycle ... management and health care industries, today announced that ... the company and will lead its debt management ... direction of all Ontario debt management solutions, including ...
... tied to this nutritional deficit , , FRIDAY, May ... may contribute to cancer development, U.S. researchers have found. ... communication among cells due to, among other things, low ... an epidemiologist at the Moores Cancer Center at the ...
... findings could alter treatment methods, , , THURSDAY, May 21 (HealthDay ... amputated because of diabetes were reduced by 36 percent when ... to lower their blood fat levels, new research has found. ... who took either 200 milligrams of fenofibrate or a placebo ...
... Patients under 44 were three times more likely to die, ... Younger men diagnosed with advanced prostate cancer don,t live as ... study finds. , "Overall, young men with prostate cancer do ... prostate cancers did substantially worse than old men with similar ...
... May 22 The National Board of Certification for ... performance exam that will be part of the testing ... weeks, 300 interpreters will "test the test" designed to ... and skills in real-life medical interpreting scenarios. This process ...
Cached Medicine News:Health News:Cephalon Announces Exercise of $65 Million Over-allotment Option on 2.50% Convertible Senior Subordinated Notes 2Health News:Cephalon Announces Exercise of $65 Million Over-allotment Option on 2.50% Convertible Senior Subordinated Notes 3Health News:Cephalon Announces Exercise of $65 Million Over-allotment Option on 2.50% Convertible Senior Subordinated Notes 4Health News:Cutler to Direct Debt Management Product Strategy at Ontario Systems 2Health News:Drug May Lessen Amputation Risk for Diabetics 2Health News:Advanced Prostate Cancer Deadlier in Younger Men 2Health News:Advanced Prostate Cancer Deadlier in Younger Men 3Health News:National Medical Interpreter Certification Testing Enters Pilot Phase 2Health News:National Medical Interpreter Certification Testing Enters Pilot Phase 3
(Date:8/28/2015)... , Aug. 28, 2015  Today, in final ... (CDC) Contact Lens Health Week, 1-800 Contacts is sharing ... found that contact lens wearers who do not properly ... risk for eye infections. Most contact ... lenses, but a clean lens case is sometimes overlooked.  ...
(Date:8/28/2015)... Aug. 28, 2015 Research ... of the "Investigation Report on China,s Ranibizumab Market, ... by Novartis, ranibizumab was approved by CFDA to treat ... only Lucentis, a product of Novartis, is available in ... first self- developed drug for the treatment of wet ...
(Date:8/28/2015)... , FARUM, Denmark and ... On July 31, 2015 the US Food and Drug Administration ... of Major Depressive Disorder in adult patients who have failed ... current episode. TMS is a non-invasive technique for stimulating neural ... suffering from Major Depressive Disorder. The procedure has been proven ...
Breaking Medicine Technology:1-800 Contacts Shares Tips on How to Clean Lens Cases 2Investigation Report on China's Ranibizumab Market, 2012-2019 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3
... March 16, 2011 Unilife Corporation ("Unilife" or the "Company") ... its Chief Executive Officer, Alan Shortall, has made open market ... the Australian Stock Exchange (ASX). Mr. Shortall, who ... 632,713 CDIs at an average price of A$0.795 (US$0.80) per ...
... /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, ... CMED ), a leading ... company, today announced that it ... following investor conferences and events: ...
Cached Medicine Technology:Unilife CEO Makes Open Market Purchase of A$500,000 in Company's Publicly Traded Shares 2Unilife CEO Makes Open Market Purchase of A$500,000 in Company's Publicly Traded Shares 3China Medical Technologies to Meet Investors 2
Desmarres Lid Retractor thin solid blades. Size 2....
... of the AMO Prestige System marked ... The combination of safety with high-performance ... of fluidic conditions in the in ... Pump" orchestrates the reaction and interaction ...
Highly versatile, efficient, compact and accurate digital readout display....
... phaco system has all the features of ... dependable engineering means minimal maintenance. Small, light ... site to site. Lowest cost reusable tubing ... No longer is there a price objection ...
Medicine Products: